Downregulation of hepatic ceruloplasmin ameliorates NAFLD via SCO1-AMPK-LKB1 complex

被引:32
|
作者
Xie, Liping [1 ]
Yuan, Yanmei [1 ]
Xu, Simiao [2 ,3 ]
Lu, Sijia [1 ]
Gu, Jinyang [4 ]
Wang, Yanping [1 ]
Wang, Yibing [5 ]
Zhang, Xianjing [1 ]
Chen, Suzhen [1 ]
Li, Jian [1 ]
Lu, Junxi [1 ]
Sun, Honglin [1 ]
Hu, Ruixiang [2 ,6 ]
Piao, Hailong [7 ]
Wang, Wen [7 ]
Wang, Cunchuan [6 ]
Wang, Jing [8 ]
Li, Na [8 ]
White, Morris F. [9 ]
Han, Liu [1 ]
Jia, Weiping [1 ]
Miao, Ji [2 ,9 ]
Liu, Junli [1 ]
机构
[1] Shanghai Jiao Tong Univ, Dept Endocrinol & Metab, Shanghai Peoples Hosp 6,Shanghai Diabet Inst, Shanghai Key Lab Diabet Mellitus,Sch Med, Shanghai 200233, Peoples R China
[2] Boston Childrens Hosp, Div Endocrinol, Boston, MA 02215 USA
[3] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll,Div Endocrinol, Branch Natl Clin Res Ctr Metab Dis, Wuhan 430030, Hubei, Peoples R China
[4] Shanghai Jiao Tong Univ, Dept Transplantat, Xinhua Hosp, Sch Med, Shanghai 200042, Peoples R China
[5] Shanghai Univ Sports, Sch Kinesiol, Shanghai 200438, Peoples R China
[6] Jinan Univ, Affiliated Hosp 1, Dept Gastrointestinal Surg, Guangzhou 510630, Guangdong, Peoples R China
[7] Chinese Acad Sci, Dalian Inst Chem Phys, CAS Key Lab Separat Sci Analyt Chem, Dalian 116023, Liaoning, Peoples R China
[8] Peking Univ, Sch Pharmaceut Sci, Dept Chem Biol, State Key Lab Nat & Biomimet Drugs, Beijing 100191, Peoples R China
[9] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA
来源
CELL REPORTS | 2022年 / 41卷 / 03期
基金
中国博士后科学基金; 中国国家自然科学基金;
关键词
TERT-BUTYL ETHER; GENE-EXPRESSION; COPPER DEFICIENCY; SERUM CERULOPLASMIN; RAT CERULOPLASMIN; HIGH-FRUCTOSE; AMPK; LIVER; TISSUE; IRON;
D O I
10.1016/j.celrep.2022.111498
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Copper deficiency has emerged to be associated with various lipid metabolism diseases, including non-alcoholic fatty liver disease (NAFLD). However, the mechanisms that dictate the association between cop-per deficiency and metabolic diseases remain obscure. Here, we reveal that copper restoration caused by hepatic ceruloplasmin (Cp) ablation enhances lipid catabolism by promoting the assembly of copper-load SCO1-LKB1-AMPK complex. Overnutrition-mediated Cp elevation results in hepatic copper loss, whereas Cp ablation restores copper content to the normal level without eliciting detectable hepatotoxicity and ame-liorates NAFLD in mice. Mechanistically, SCO1 constitutively interacts with LKB1 even in the absence of copper, and copper-loaded SCO1 directly tethers LKB1 to AMPK, thereby activating AMPK and conse-quently promoting mitochondrial biogenesis and fatty acid oxidation. Therefore, this study reveals a mech-anism by which copper, as a signaling molecule, improves hepatic lipid catabolism, and it indicates that targeting copper-SCO1-AMPK signaling pathway ameliorates NAFLD development by modulating AMPK activity.
引用
收藏
页数:28
相关论文
共 50 条
  • [1] Comments on Downregulation of hepatic ceruloplasmin ameliorates NAFLD via SCO1-AMPK-LKB1 complex'
    Lu, Sijia
    Chen, Suzhen
    Miao, Ji
    Liu, Junli
    JOURNAL OF MOLECULAR CELL BIOLOGY, 2023, 15 (04)
  • [2] Ginsenoside CK ameliorates hepatic lipid accumulation via activating the LKB1/AMPK pathway in vitro and in vivo
    Zhang, Jingjing
    Ma, Xiaoxuan
    Fan, Daidi
    FOOD & FUNCTION, 2022, 13 (03) : 1153 - 1167
  • [3] Klotho ameliorates diabetic nephropathy via LKB1-AMPK-PGC1α-mediated renal mitochondrial protection
    Lee, Jinho
    Tsogbadrakh, Bodokhsuren
    Yang, SeungHee
    Ryu, Hyunjin
    Kang, Eunjung
    Kang, Minjung
    Kang, Hee Gyung
    Ahn, Curie
    Oh, Kook-Hwan
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2021, 534 : 1040 - 1046
  • [4] Laurolitsine ameliorates type 2 diabetes by regulating the hepatic LKB1-AMPK pathway and gut microbiota
    Zhang, Yong
    Wang, Ruiqi
    Yang, Yanan
    Ma, Ning
    Zhou, Zhi
    Tan, Yinfeng
    Dong, Lin
    Li, Yiying
    Lu, Weiying
    Wu, Chongming
    Zhang, Xiaopo
    PHYTOMEDICINE, 2022, 106
  • [5] LKB1 suppression promotes cardiomyocyte regeneration via LKB1-AMPK-YAP axis
    Qu, Shuang
    Liao, Qiao
    Yu, Cheng
    Chen, Yue
    Luo, Hao
    Xia, Xuewei
    He, Duofen
    Xu, Zaicheng
    Jose, Pedro A.
    Li, Zhuxin
    Wang, Wei Eric
    Lyu, Qing Rex
    Zeng, Chunyu
    BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2022, 22 (05) : 772 - 783
  • [6] Paeoniflorin Ameliorates Fructose-Induced Insulin Resistance and Hepatic Steatosis by Activating LKB1/AMPK and AKT Pathways
    Li, Yu-Cheng
    Qiao, Jing-Yi
    Wang, Bao-Ying
    Bai, Ming
    Shen, Ji-Duo
    Cheng, Yong-Xian
    NUTRIENTS, 2018, 10 (08)
  • [7] Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state
    Foretz, Marc
    Hebrard, Sophie
    Leclerc, Jocelyne
    Zarrinpashneh, Elham
    Soty, Maud
    Mithieux, Gilles
    Sakamoto, Kei
    Andreelli, Fabrizio
    Viollet, Benoit
    JOURNAL OF CLINICAL INVESTIGATION, 2010, 120 (07): : 2355 - 2369
  • [8] Role of AMPK and SIK in the LKB1-dependent Regulation of Hepatic Gluconeogenesis
    Marion, Allison
    Boudaba, Nadia
    Sakamoto, Kei
    Viollet, Benoit
    Foretz, Marc
    DIABETES, 2014, 63 : A463 - A463
  • [9] DEC1 negatively regulates AMPK activity via LKB1
    Sato, Fuyuki
    Muragaki, Yasuteru
    Zhang, Yanping
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2015, 467 (04) : 711 - 716
  • [10] DEC1 negatively regulates AMPK activity via LKB1
    Sato, Fuyuki
    Muragaki, Yasuteru
    CANCER RESEARCH, 2016, 76